Experimental drug for COVID-19 ‘fails’ in first human trial

Experimental drug for COVID-19 ‘fails’ in first human trial

- The World Health Organization gave an update about an experimental drug for COVID-19

- It said that the antiviral drug called remdesivir failed in its first human trial

- The organization also revealed that the trial needed to be stopped early because of side effects

- The company behind the said drug refuted the announcement of WHO

PAY ATTENTION: Click "See First" under the "Following" tab to see KAMI news on your News Feed

An experimental drug that was made to treat patients of the novel coronavirus disease (COVID-19) has failed in its first human trial.

KAMI learned that the said development was recently announced by the World Health Organization (WHO) through social media.

It stated that the antiviral drug called “remdesivir” did not improve the patients’ condition or even reduce the presence of pathogen in their bloodstream.

The drug was administered to 158 people and the results were compared with the 79 patients who received placebo.

According to WHO, 13.9 percent of the patients who took remdesivir have died. It was higher than the 12.8 percent from those who received placebo.

The trial was also reportedly stopped early because of the side effects that were noticed from the patients.

"Remdesivir was not associated with clinical or virological benefits," the post said.

Experimental drug for COVID-19 ‘fails’ in first human trial

PAY ATTENTION: Enjoyed reading our story? Download KAMI's news app on Google Play now and stay up-to-date with major Filipino news!

Gilead Sciences, the company behind the said antiviral drug, has refuted the findings published by the WHO.

It pointed out that the statement of the said organization mischaracterized the study and that it was stopped early because of “low enrolment.”

"As such, the study results are inconclusive, though trends in the data suggest a potential benefit for remdesivir, particularly among patients treated early in disease," Gilead spokesman quipped.

In a previous article by KAMI, a vaccine candidate for the COVID-19 received an approval to proceed to the second phase of clinical trials.

The novel coronavirus disease continues to wreak havoc in more than 200 countries and territories. In the Philippines, the total number of confirmed cases reaches 7,192.

Please like and share our Facebook posts to support KAMI team! Don’t hesitate to comment and share your opinion about our stories either. We love reading about your thoughts!

A Filipino found his own way to help frontliners amid pandemic. “They had to walk an hour, an hour and a half to get to work. I mean, coming from an 8-hour shift sa hospital, tapos palalakarin mo pa yung nurse o kahit security guard. Parang hindi makatarungan, diba?” – on HumanMeter!

Source: Kami.com.ph

Online view pixel